Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 264

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies

Margaux Soulard, Lionel Galicier, Nizar Mahlaoui, Claire Fieschi, Samuel Deshayes, Delphine Gobert, Clément Gourguechon, Hélène Henique, Sebastien Humbert, Carole Lacout, Ronan Le Calloch, Marc Michel, Marie-lea Piel-julian, Jean François Viallard, Alain Lescoat, Bertrand Godeau, Antoinette Perlat

Blood Adv (2024) 8 (24): 6171–6182.

https://doi.org/10.1182/bloodadvances.2024014370

Published: 2024

Journal Articles

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Sébastien Héritier, Helder Fernandes, Thomas Kühne

Blood Adv (2024) 8 (24): 6183–6194.

https://doi.org/10.1182/bloodadvances.2024014381

Published: 2024

Includes: Supplemental data

Journal Articles

Pediatric refractory ITP, a definition to be defined

Emilia Parodi, Giovanna Russo

Blood Adv bloodadvances.2024015195.

https://doi.org/10.1182/bloodadvances.2024015195

Published: 2024

Journal Articles

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study

Blood Adv bloodadvances.2024014984.

https://doi.org/10.1182/bloodadvances.2024014984

Published: 2024

Includes: Supplemental data

Journal Articles

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Halina H. L. Leung, Zohra Ahmadi, Brendan Lee, John Casey, Sumita Ratnasingam, Steven E. McKenzie, Jose Perdomo, Beng H. Chong

Blood Adv (2024) 8 (22): 5744–5752.

https://doi.org/10.1182/bloodadvances.2024013883

Published: 2024

Includes: Supplemental data

Journal Articles

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice

Blood Adv (2024) 8 (21): 5557–5570.

https://doi.org/10.1182/bloodadvances.2024012713

Published: 2024

Includes: Supplemental data

Journal Articles

Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction

Marcel Benkhoff, Karin Alde, Vincent Ehreiser, Jana Dahlmanns, Daniel Metzen, Jean M. Haurand, Dragos Andrei Duse, Christian Jung, Malte Kelm, Tobias Petzold, Amin Polzin

Blood Adv (2024) 8 (21): 5581–5589.

https://doi.org/10.1182/bloodadvances.2024014273

Published: 2024

Includes: Supplemental data

Journal Articles

Patients with Waldenström macroglobulinemia have impaired platelet and coagulation function

Simone A. Brysland, Dipti Talaulikar, Sarah M. Hicks, James I. Hearn, Sidra A. Ali, Muhammad Gohar Maqbool, Mridula Mokoonlall, Vijay Bhoopalan, Amandeep Kaur, Yee Lin Thong, Robert K. Andrews, James C. Whisstock, Philip J. Crispin, Elizabeth E. Gardiner

Blood Adv (2024) 8 (21): 5542–5555.

https://doi.org/10.1182/bloodadvances.2024014190

Published: 2024

Includes: Supplemental data

Journal Articles

Btk inhibition: the importance of being selective

Robert Flaumenhaft

Blood Adv (2024) 8 (21): 5579–5580.

https://doi.org/10.1182/bloodadvances.2024014009

Published: 2024

Journal Articles

Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia

Taylor Olmsted Kim, Jennifer M. Geris, Jonathan M. Flanagan, Rachael F. Grace, Michele P. Lambert, Candelaria O’Farrell, Melissa J. Rose, Kristin A. Shimano, Omar Niss, Cindy Neunert, Taizo A. Nakano, Derek MacMath, Bogdan Dinu, Susan E. Kirk, Ellis J. Neufeld, Jenny M. Despotovic, Michael E. Scheurer, Amanda B. Grimes

Blood Adv (2024) 8 (21): 5529–5538.

https://doi.org/10.1182/bloodadvances.2024012776

Published: 2024

Includes: Supplemental data

Journal Articles

Is GPIbα really a master regulator of platelet activation?

Brianna Ellen Watson, Isabelle I Salles-Crawley

Blood Adv bloodadvances.2024014324.

https://doi.org/10.1182/bloodadvances.2024014324

Published: 2024

Journal Articles

Unbiased High-Throughput Screening of Drug-Repurposing Libraries Identifies Small-Molecule Inhibitors of Clot Retraction

Lorena Buitrago, Miriam-Rose Menezes, Chloe Larson, Jihong Li, Thomas Kartika, Priyam Banerjee, Fraser Glickman, Barry S. Coller

Blood Adv bloodadvances.2024013810.

https://doi.org/10.1182/bloodadvances.2024013810

Published: 2024

Includes: Supplemental data

Journal Articles

Immunoglobulins act as predictors of chronicity in pediatric immune thrombocytopenia

Kirsty Hillier, Derek MacMath, Jessica Chumsky, Susan E. Kirk, Candelaria O’Farrell, Taylor Olmsted Kim, Mark Zobeck, Amanda B. Grimes

Blood Adv (2024) 8 (19): 5118–5121.

https://doi.org/10.1182/bloodadvances.2024013222

Published: 2024

Journal Articles

What is in a name: defining pediatric refractory ITP

Blood Adv (2024) 8 (19): 5112–5117.

https://doi.org/10.1182/bloodadvances.2024012707

Published: 2024

Journal Articles

Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation

Yaqiu Sang, Robert H. Lee, Annie Luong, Éva Katona, Claire S. Whyte, Nicholas L. Smith, Alan E. Mast, Matthew J. Flick, Nicola J. Mutch, Wolfgang Bergmeier, Alisa S. Wolberg

Blood Adv (2024) 8 (19): 5072–5085.

https://doi.org/10.1182/bloodadvances.2024012979

Published: 2024

Includes: Supplemental data

Journal Articles

Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients

Aaron B. Boothby, Matthew K. Tanner, Abdullah Alswied, Danny Youngs, Josefine Bribiesca Rodriguez, Thejaswi Bikkani, Nuri Cha, Terry Gernsheimer, Idoia Gimferrer, John R. Hess, Lauge Sokol-Hessner, Snigdha Marivada, Michael G. Nash, Willy A. Flegel, Ralph R. Vassallo, David F. Stroncek, Hamilton C. Tsang, Sandhya R. Panch

Blood Adv (2024) 8 (17): 4689–4699.

https://doi.org/10.1182/bloodadvances.2024014143

Published: 2024

Includes: Supplemental data

Journal Articles

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience

Alice Taylor, Louisa Keogh, Emmy Dickens, Tina Dutt, John Grainger, Rennick Gregory, Claire Mapplebeck, Michael Richards, Simone Stokley, Styliani Salta, Thomas Taylor, Marie Scully

Blood Adv (2024) 8 (17): 4563–4567.

https://doi.org/10.1182/bloodadvances.2024013488

Published: 2024

Journal Articles

Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis

Omid Seidizadeh, Andrea Cairo, Ilaria Mancini, James N. George, Flora Peyvandi

Blood Adv (2024) 8 (16): 4386–4396.

https://doi.org/10.1182/bloodadvances.2024013421

Published: 2024

Includes: Supplemental data

Journal Articles

An αIIbβ3 monoclonal antibody traps a semiextended conformation and allosterically inhibits large ligand binding

Lu Wang, Jialing Wang, Jihong Li, Thomas Walz, Barry S. Coller

Blood Adv (2024) 8 (16): 4398–4409.

https://doi.org/10.1182/bloodadvances.2024013177

Published: 2024

Includes: Supplemental data

Journal Articles

Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms

Sarah Kelliher, Sara Gamba, Luisa Weiss, Zhu Shen, Marina Marchetti, Francesca Schieppati, Caitriona Scaife, Stephen Madden, Kathleen Bennett, Anne Fortune, Su Maung, Michael Fay, Fionnuala Ní Áinle, Patricia Maguire, Anna Falanga, Barry Kevane, Anandi Krishnan

Blood Adv (2024) 8 (16): 4276–4280.

https://doi.org/10.1182/bloodadvances.2023012016

Published: 2024

Includes: Supplemental data

NARROW

Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Pediatric refractory ITP, a definition to be defined

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice

Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction

Patients with Waldenström macroglobulinemia have impaired platelet and coagulation function

Btk inhibition: the importance of being selective

Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia

Is GPIbα really a master regulator of platelet activation?

Unbiased High-Throughput Screening of Drug-Repurposing Libraries Identifies Small-Molecule Inhibitors of Clot Retraction

Immunoglobulins act as predictors of chronicity in pediatric immune thrombocytopenia

What is in a name: defining pediatric refractory ITP

Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation

Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience

Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis

An αIIbβ3 monoclonal antibody traps a semiextended conformation and allosterically inhibits large ligand binding

Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only